{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T11:20:23Z","timestamp":1775042423033,"version":"3.50.1"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T00:00:00Z","timestamp":1638921600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>Mannose-binding lectins effectively inhibit most seasonal strains of influenza A virus and contribute to the innate host defense vs. these viruses. In contrast, pandemic IAV strains are largely resistant to these lectins, likely contributing to increased spread and worse outcomes. In this paper, we evaluated the inhibition of IAV by mannose-binding lectins of human, bacterial, and fungal origin to understand and possibly increase activity vs. the pandemic IAV. A modified version of the human surfactant protein D (SP-D) neck and carbohydrate recognition domain (NCRD) with combinatorial substitutions at the 325 and 343 positions, previously shown to inhibit pandemic H3N2 IAV<jats:italic>in vitro<\/jats:italic>and<jats:italic>in vivo<\/jats:italic>, and to inhibit pandemic H1N1<jats:italic>in vitro<\/jats:italic>, failed to protect mice from pandemic H1N1<jats:italic>in vivo<\/jats:italic>in the current study. We attempted a variety of maneuvers to improve the activity of the mutant NCRDs vs. the 2009 pandemic H1N1, including the formation of full-length SP-D molecules containing the mutant NCRD, cross-linking of NCRDs through the use of antibodies, combining SP-D or NCRDs with alpha-2-macroglobulin, and introducing an additional mutation to the double mutant NCRD. None of these substantially increased the antiviral activity for the pandemic H1N1. We also tested the activity of bacterial and algal mannose-binding lectins, cyanovirin, and griffithsin, against IAV. These had strong activity against seasonal IAV, which was largely retained against pandemic H1N1. We propose mechanisms to account for differences in activity of SP-D constructs against pandemic H3N2 and H1N1, and for differences in activity of cyanovirin vs. SP-D constructs.<\/jats:p>","DOI":"10.3389\/fmicb.2021.774711","type":"journal-article","created":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T04:18:23Z","timestamp":1638937103000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Viral Evasion of Innate Immune Defense: The Case of Resistance of Pandemic H1N1 Influenza A Virus to Human Mannose-Binding Proteins"],"prefix":"10.3389","volume":"12","author":[{"given":"Mitchell R.","family":"White","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos M.","family":"Nikolaidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis","family":"McCormack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika C.","family":"Crouch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevan L.","family":"Hartshorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,12,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01586","article-title":"Entry inhibition and modulation of pro-inflammatory immune response against influenza A virus by a recombinant truncated surfactant protein D.","volume":"9","author":"Al-Ahdal","year":"2018","journal-title":"Front. Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.virol.2020.01.017","article-title":"Comparison of the antiviral activity of the microbicide candidate griffithsin and its tandemers derivatives against different modes of HIV-1 transmission.","volume":"544","author":"Alexandre","year":"2020","journal-title":"Virology"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00204-19","article-title":"Human influenza A virus hemagglutinin glycan evolution follows a temporal pattern to a glycan limit.","volume":"10","author":"Altman","year":"2019","journal-title":"mBio"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1002\/pmic.200900775","article-title":"The essentiality of alpha-2-macroglobulin in human salivary innate immunity against new H1N1 swine origin influenza A virus.","volume":"10","author":"Chen","year":"2010","journal-title":"Proteomics"},{"key":"B5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1196\/annals.1299.019","article-title":"A recombinant fragment of human surfactant protein D reduces alveolar macrophage apoptosis and pro-inflammatory cytokines in mice developing pulmonary emphysema.","volume":"1010","author":"Clark","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"13461","DOI":"10.1074\/jbc.M110.108837","article-title":"Surfactant protein D interacts with alpha2-macroglobulin and increases its innate immune potential.","volume":"285","author":"Craig-Barnes","year":"2010","journal-title":"J. Biol. Chem."},{"key":"B7","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.1021\/bi8022703","article-title":"Recognition of mannosylated ligands and influenza A virus by human surfactant protein D: contributions of an extended site and residue 343.","volume":"48","author":"Crouch","year":"2009","journal-title":"Biochemistry"},{"key":"B8","doi-asserted-by":"publisher","first-page":"18008","DOI":"10.1074\/jbc.M601749200","article-title":"Contributions of phenylalanine 335 to ligand recognition by human surfactant protein D: ring interactions with SP-D ligands.","volume":"281","author":"Crouch","year":"2006","journal-title":"J. Biol. Chem."},{"key":"B9","doi-asserted-by":"publisher","first-page":"40681","DOI":"10.1074\/jbc.M111.300673","article-title":"Mutagenesis of surfactant protein D informed by evolution and x-ray crystallography enhances defenses against influenza A virus in vivo.","volume":"286","author":"Crouch","year":"2011","journal-title":"J. Biol. Chem."},{"key":"B10","doi-asserted-by":"publisher","first-page":"8527","DOI":"10.1021\/bi4010683","article-title":"Molecular mechanisms of inhibition of influenza by surfactant protein D revealed by large-scale molecular dynamics simulation.","volume":"52","author":"Goh","year":"2013","journal-title":"Biochemistry"},{"key":"B11","doi-asserted-by":"publisher","first-page":"4358","DOI":"10.1128\/JVI.66.7.4358-4363.1992","article-title":"Two distinct serum mannose-binding lectins function as beta inhibitors of influenza virus: identification of bovine serum beta inhibitor as conglutinin.","volume":"66","author":"Hartley","year":"1992","journal-title":"J. Virol."},{"key":"B12","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.4049\/jimmunol.141.4.1295","article-title":"Effects of influenza A virus on human neutrophil calcium metabolism.","volume":"141","author":"Hartshorn","year":"1988","journal-title":"J. Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1172\/JCI117323","article-title":"Evidence for a protective role of pulmonary surfactant protein D (SP-D) against influenza A viruses.","volume":"94","author":"Hartshorn","year":"1994","journal-title":"J. Clin. Invest."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-9-65","article-title":"Role of viral hemagglutinin glycosylation in anti-influenza activities of recombinant surfactant protein D.","volume":"9","author":"Hartshorn","year":"2008","journal-title":"Respir. Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1365-3083.2010.02409.x","article-title":"Increasing antiviral activity of surfactant protein d trimers by introducing residues from bovine serum collectins: dissociation of mannan-binding and antiviral activity.","volume":"72","author":"Hartshorn","year":"2010","journal-title":"Scand. J. Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"L753","DOI":"10.1152\/ajplung.1996.271.5.L753","article-title":"Interactions of recombinant human pulmonary surfactant protein D and SP-D multimers with influenza A.","volume":"271","author":"Hartshorn","year":"1996","journal-title":"Am. J. Physiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"8565","DOI":"10.1128\/JVI.78.16.8565-8572.2004","article-title":"Pulmonary collectins modulate strain-specific influenza a virus infection and host responses.","volume":"78","author":"Hawgood","year":"2004","journal-title":"J. Virol."},{"key":"B18","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01368","article-title":"The role and molecular mechanism of action of surfactant protein d in innate host defense against influenza A virus.","volume":"9","author":"Hsieh","year":"2018","journal-title":"Front. Immunol."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.641360","article-title":"Human surfactant protein D binds spike protein and acts as an entry inhibitor of SARS-CoV-2 pseudotyped viral particles.","volume":"12","author":"Hsieh","year":"2021","journal-title":"Front. Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.virol.2007.06.029","article-title":"High-mannose-specific deglycosylation of HIV-1 gp120 induced by resistance to cyanovirin-N and the impact on antibody neutralization.","volume":"368","author":"Hu","year":"2007","journal-title":"Virology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1042\/BJ20112101","article-title":"Glycosylation at Asn91 of H1N1 haemagglutinin affects binding to glycan receptors.","volume":"444","author":"Jayaraman","year":"2012","journal-title":"Biochem. J."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1128\/JVI.02553-13","article-title":"Differential inhibitory effects of cyanovirin-N, griffithsin, and scytovirin on entry mediated by envelopes of gammaretroviruses and deltaretroviruses.","volume":"88","author":"Jensen","year":"2014","journal-title":"J. Virol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.4049\/jimmunol.1202433","article-title":"Addition of glycosylation to influenza A virus hemagglutinin modulates antibody-mediated recognition of H1N1 2009 pandemic viruses.","volume":"190","author":"Job","year":"2013","journal-title":"J. Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"4284","DOI":"10.4049\/jimmunol.1001613","article-title":"Pandemic H1N1 influenza A viruses are resistant to the antiviral activities of innate immune proteins of the collectin and pentraxin superfamilies.","volume":"185","author":"Job","year":"2010","journal-title":"J. Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1074\/mcp.M116.058016","article-title":"Integrated omics and computational glycobiology reveal structural basis for influenza A virus glycan microheterogeneity and host interactions.","volume":"15","author":"Khatri","year":"2016","journal-title":"Mol. Cell Proteomics"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-8-70","article-title":"Truncated recombinant human SP-D attenuates emphysema and type II cell changes in SP-D deficient mice.","volume":"8","author":"Knudsen","year":"2007","journal-title":"Respir. Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/nature05495","article-title":"Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus.","volume":"445","author":"Kobasa","year":"2007","journal-title":"Nature"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/md17100567","article-title":"Griffithsin, a highly potent broad-spectrum antiviral lectin from red algae: from discovery to clinical application.","volume":"17","author":"Lee","year":"2019","journal-title":"Mar. Drugs"},{"key":"B29","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.imbio.2006.12.001","article-title":"The SARS coronavirus spike glycoprotein is selectively recognized by lung surfactant protein D and activates macrophages.","volume":"212","author":"Leth-Larsen","year":"2007","journal-title":"Immunobiology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.1099\/vir.0.80764-0","article-title":"Surfactant protein D binds to human immunodeficiency virus (HIV) envelope protein gp120 and inhibits HIV replication.","volume":"86","author":"Meschi","year":"2005","journal-title":"J. Gen. Virol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"L1036","DOI":"10.1152\/ajplung.00035.2014","article-title":"Mutations flanking the carbohydrate binding site of surfactant protein D confer antiviral activity for pandemic influenza A viruses.","volume":"306","author":"Nikolaidis","year":"2014","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"B32","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01951-19","article-title":"Influenza virus hemagglutinins H2, H5, H6, and H11 are not targets of pulmonary surfactant protein D: N-Glycan subtypes in host-pathogen interactions.","volume":"94","author":"Parsons","year":"2020","journal-title":"J. Virol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.virol.2011.01.029","article-title":"The ability of pandemic influenza virus hemagglutinins to induce lower respiratory pathology is associated with decreased surfactant protein D binding.","volume":"412","author":"Qi","year":"2011","journal-title":"Virology"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02116-14","article-title":"Contemporary avian influenza a virus subtype h1, h6, h7, h10, and h15 hemagglutinin genes encode a Mammalian virulence factor similar to the 1918 pandemic virus h1 hemagglutinin.","volume":"5","author":"Qi","year":"2014","journal-title":"mBio"},{"key":"B35","doi-asserted-by":"publisher","first-page":"8204","DOI":"10.1128\/JVI.71.11.8204-8212.1997","article-title":"Collectin-mediated antiviral host defense of the lung: evidence from influenza virus infection of mice.","volume":"71","author":"Reading","year":"1997","journal-title":"J. Virol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.antiviral.2008.06.003","article-title":"Treatment of influenza A (H1N1) virus infections in mice and ferrets with cyanovirin-N.","volume":"80","author":"Smee","year":"2008","journal-title":"Antiviral Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1177\/095632020701800604","article-title":"Influenza A (H1N1) virus resistance to cyanovirin-N arises naturally during adaptation to mice and by passage in cell culture in the presence of the inhibitor.","volume":"18","author":"Smee","year":"2007","journal-title":"Antivir. Chem. Chemother."},{"key":"B38","doi-asserted-by":"crossref","first-page":"8756","DOI":"10.1128\/JVI.00593-13","article-title":"N-linked glycosylation of the hemagglutinin protein influences virulence and antigenicity of the 1918 pandemic and seasonal H1N1 influenza A viruses.","volume":"87","author":"Sun","year":"2013","journal-title":"J. Virol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.4049\/jimmunol.1100295","article-title":"Specific sites of N-linked glycosylation on the hemagglutinin of H1N1 subtype influenza A virus determine sensitivity to inhibitors of the innate immune system and virulence in mice.","volume":"187","author":"Tate","year":"2012","journal-title":"J. Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1042\/BJ20071663","article-title":"Critical role for cross-linking of trimeric lectin domains of surfactant protein D in antiviral activity against influenza A virus.","volume":"412","author":"Tecle","year":"2008","journal-title":"Biochem. J."},{"key":"B41","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1177\/1753425913508992","article-title":"The amazing innate immune response to influenza A virus infection.","volume":"21","author":"Tripathi","year":"2013","journal-title":"Innate Immun."},{"key":"B42","doi-asserted-by":"publisher","first-page":"20137","DOI":"10.1074\/jbc.M111.224469","article-title":"Introduction of N-linked glycans in the lectin domain of surfactant protein D: impact on interactions with influenza A viruses.","volume":"286","author":"van Eijk","year":"2011","journal-title":"J. Biol. Chem."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02476","article-title":"Enhanced antiviral activity of human surfactant protein D by site-specific engineering of the carbohydrate recognition domain.","volume":"10","author":"van Eijk","year":"2019","journal-title":"Front. Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"26666","DOI":"10.1074\/jbc.M112.368571","article-title":"A unique sugar-binding site mediates the distinct anti-influenza activity of pig surfactant protein D.","volume":"287","author":"van Eijk","year":"2012","journal-title":"J. Biol. Chem."},{"key":"B45","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1165\/rcmb.2003-0355OC","article-title":"Interactions of influenza A virus with sialic acids present on porcine surfactant protein D.","volume":"30","author":"van Eijk","year":"2004","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1080\/22221751.2020.1739565","article-title":"Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26.","volume":"9","author":"Vankadari","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"B47","doi-asserted-by":"publisher","first-page":"8593","DOI":"10.1128\/JVI.00769-07","article-title":"N-linked glycosylation attenuates H3N2 influenza viruses.","volume":"81","author":"Vigerust","year":"2007","journal-title":"J. Virol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1159\/000272313","article-title":"Enhancement of antiviral activity of collectin trimers through cross-linking and mutagenesis of the carbohydrate recognition domain.","volume":"2","author":"White","year":"2010","journal-title":"J. Innate Immun."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2021.774711\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T16:31:34Z","timestamp":1673973094000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2021.774711\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,8]]},"references-count":48,"alternative-id":["10.3389\/fmicb.2021.774711"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2021.774711","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,8]]},"article-number":"774711"}}